Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaro

Showing results (301-310 of 422) with videos related to

Pageof 43
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2020
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart StudyLaura S Chiu, Alison Pedley, Joseph M Massaro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham StudyJohn F Keaney, Martin G Larson, Ramachandran S Vasan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart studySarah Rosner Preis, Joseph M Massaro, Udo Hoffmann, et al.
Diabetes Technology & Therapeutics|December 21, 2016
Hypoglycemia in Older Adults with Type 1 DiabetesStephanie N DuBose, Ruth S Weinstock, Roy W Beck, et al.
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Journal of Interventional Cardiology|December 17, 2013
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella RegistryWilliam W O'Neill, Theodore Schreiber, David H W Wohns, et al.
American Heart Journal|December 15, 2010
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesionsLaura Mauri, Dean J Kereiakes, Sharon-Lise T Normand, et al.
The American Journal of Cardiology|March 19, 2013
Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study)Ian S Rogers, Joseph M Massaro, Quynh A Truong, et al.
The New England Journal of Medicine|March 13, 2013
Nonemergency PCI at hospitals with or without on-site cardiac surgeryAlice K Jacobs, Sharon-Lise T Normand, Joseph M Massaro, et al.
Journal of the American College of Cardiology|July 6, 2004
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring StudyJohn F Keaney, Joseph M Massaro, Martin G Larson, et al.
Pageof 43

Showing results (301-310 of 422) with videos related to

Sort By:
Pageof 43
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2020
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart StudyLaura S Chiu, Alison Pedley, Joseph M Massaro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham StudyJohn F Keaney, Martin G Larson, Ramachandran S Vasan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart studySarah Rosner Preis, Joseph M Massaro, Udo Hoffmann, et al.
Diabetes Technology & Therapeutics|December 21, 2016
Hypoglycemia in Older Adults with Type 1 DiabetesStephanie N DuBose, Ruth S Weinstock, Roy W Beck, et al.
Atherosclerosis|September 15, 2005
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1qJosée Dupuis, Martin G Larson, Ramachandran S Vasan, et al.
Journal of Interventional Cardiology|December 17, 2013
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella RegistryWilliam W O'Neill, Theodore Schreiber, David H W Wohns, et al.
American Heart Journal|December 15, 2010
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesionsLaura Mauri, Dean J Kereiakes, Sharon-Lise T Normand, et al.
The American Journal of Cardiology|March 19, 2013
Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study)Ian S Rogers, Joseph M Massaro, Quynh A Truong, et al.
The New England Journal of Medicine|March 13, 2013
Nonemergency PCI at hospitals with or without on-site cardiac surgeryAlice K Jacobs, Sharon-Lise T Normand, Joseph M Massaro, et al.
Journal of the American College of Cardiology|July 6, 2004
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring StudyJohn F Keaney, Joseph M Massaro, Martin G Larson, et al.
Pageof 43